StockData
Perspective Therapeutics, Inc. logo

Perspective Therapeutics, Inc. (CATX) stock

CATXNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 9, 2026Score 4/30
$0.75−0.03 (-3.85%)

Close on Nov 20, 2026Market cap $86.05MP/E –Yield –

Perspective Therapeutics total debt

Total debt is short-term plus long-term borrowings on the balance sheet at the end of each period.

Perspective Therapeutics's total debt was $1.54M at Jun 30, 2026. For fiscal 2025 it was $1.57M, down 3.4% from the year before.

Annual total debt

PeriodPeriod endValueChange
FY2025Dec 31, 2025$1.57M-3.4%
FY2024Dec 31, 2024$1.63M–

Quarterly total debt

Change is against the same quarter a year earlier.

Periods
PeriodPeriod endValueChange
Q2 FY2026CQ2 2026Jun 30, 2026$1.54M-3.6%
Q1 FY2026CQ1 2026Mar 31, 2026$1.55M-3.5%
Q4 FY2025CQ4 2025Dec 31, 2025$1.57M-3.4%
Q3 FY2025CQ3 2025Sep 30, 2025$1.58M-3.4%
Q2 FY2025CQ2 2025Jun 30, 2025$1.60M-3.3%
Q1 FY2025CQ1 2025Mar 31, 2025$1.61M-3.1%
Q4 FY2024CQ4 2024Dec 31, 2024$1.63M–
Q3 FY2024CQ3 2024Sep 30, 2024$1.64M–
Q2 FY2024CQ2 2024Jun 30, 2024$1.65M–
Q1 FY2024CQ1 2024Mar 31, 2024$1.66M–

More Perspective Therapeutics figures

See a number that looks wrong?